Mercyhealth Cancer Institute - Rockford is a clinical research site located in Rockford, Illinois, United States 61114.
Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.
Mercyhealth Cancer Institute - Rockford has participated in 7 clinical trials with 7 currently active.
Therapeutic areas: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Previously Treated Non-Small Cell Lung Cancer.
Sponsors: NRG Oncology, SWOG Cancer Research Network, National Cancer Institute (NCI).
Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Mercyhealth Cancer Institute - Rockford has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Mercyhealth Cancer Institute - Rockford has 7 clinical trials on record, with 7 currently active. Their work covers Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Previously Treated Non-Small Cell Lung Cancer.
Yes — Mercyhealth Cancer Institute - Rockford holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.